Skip to main content

Advertisement

Log in

Computed-tomography-guided anatomic standardization for quantitative assessment of dopamine transporter SPECT

  • Original Article
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

Abstract

Purpose

For the quantitative assessment of dopamine transporter (DAT) using [123I]FP-CIT single-photon emission computed tomography (SPECT) (DaTscan), anatomic standardization is preferable for achieving objective and user-independent quantification of striatal binding using a volume-of-interest (VOI) template. However, low accumulation of DAT in Parkinson’s disease (PD) would lead to a deformation error when using a DaTscan-specific template without any structural information. To avoid this deformation error, we applied computed tomography (CT) data obtained using SPECT/CT equipment to anatomic standardization.

Methods

We retrospectively analyzed DaTscan images of 130 patients with parkinsonian syndromes (PS), including 80 PD and 50 non-PD patients. First we segmented gray matter from CT images using statistical parametric mapping 12 (SPM12). These gray-matter images were then anatomically standardized using the diffeomorphic anatomical registration using exponentiated Lie algebra (DARTEL) algorithm. Next, DaTscan images were warped with the same parameters used in the CT anatomic standardization. The target striatal VOIs for decreased DAT in PD were generated from the SPM12 group comparison of 20 DaTscan images from each group. We applied these VOIs to DaTscan images of the remaining patients in both groups and calculated the specific binding ratios (SBRs) using nonspecific counts in a reference area. In terms of the differential diagnosis of PD and non-PD groups using SBR, we compared the present method with two other methods, DaTQUANT and DaTView, which have already been released as software programs for the quantitative assessment of DaTscan images.

Results

The SPM12 group comparison showed a significant DAT decrease in PD patients in the bilateral whole striatum. Of the three methods assessed, the present CT-guided method showed the greatest power for discriminating PD and non-PD groups, as it completely separated the two groups.

Conclusion

CT-guided anatomic standardization using the DARTEL algorithm is promising for the quantitative assessment of DaTscan images.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Suwijn SR, van Boheemen CJ, de Haan RJ, Tissingh G, Booij J, de Bie RM. The diagnostic accuracy of dopamine transporter SPECT imaging to detect nigrostriatal cell loss in patients with Parkinson’s disease or clinically uncertain parkinsonism: a systematic review. EJNMMI Res. 2015;5:12. doi:10.1186/s13550-015-0087-1.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Politis M. Neuroimaging in Parkinson disease: from research setting to clinical practice. Nat Rev Neurol. 2014;10(12):708–22. doi:10.1038/nrneurol.2014.205.

    Article  PubMed  Google Scholar 

  3. Cummings JL, Henchcliffe C, Schaier S, Simuni T, Waxman A, Kemp P. The role of dopaminergic imaging in patients with symptoms of dopaminergic system neurodegeneration. Brain : J Neurol. 2011;134(Pt 11):3146–66. doi:10.1093/brain/awr177.

    Article  Google Scholar 

  4. Gerasimou G, Costa DC, Papanastasiou E, Bostanjiopoulou S, Arnaoutoglou M, Moralidis E, et al. SPECT study with I-123-Ioflupane (DaTSCAN) in patients with essential tremor. Is there any correlation with Parkinson’s disease? Ann Nucl Med. 2012;26(4):337–44. doi:10.1007/s12149-012-0577-4.

    Article  CAS  PubMed  Google Scholar 

  5. Thiriez C, Itti E, Fenelon G, Evangelista E, Meignan M, Cesaro P, et al. Clinical routine use of dopamine transporter imaging in 516 consecutive patients. J Neurol. 2015;262(4):909–15. doi:10.1007/s00415-014-7634-y.

    Article  CAS  PubMed  Google Scholar 

  6. Booij J, Habraken JB, Bergmans P, Tissingh G, Winogrodzka A, Wolters EC, et al. Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson’s disease. J Nucl Med : Off Publ Soc Nucl Med. 1998;39(11):1879–84.

    CAS  Google Scholar 

  7. Skanjeti A, Castellano G, Elia BO, Zotta M, Dazzara F, Manfredi M, et al. Multicenter Semiquantitative Evaluation of I-FP-CIT Brain SPECT. J Neuroimaging : Off J Am Soc Neuroimaging. 2015. doi:10.1111/jon.12242.

    Google Scholar 

  8. Tossici-Bolt L, Hoffmann SM, Kemp PM, Mehta RL, Fleming JS. Quantification of [123I]FP-CIT SPECT brain images: an accurate technique for measurement of the specific binding ratio. Eur J Nucl Med Mol Imaging. 2006;33(12):1491–9. doi:10.1007/s00259-006-0155-x.

    Article  PubMed  Google Scholar 

  9. Van Laere K, Casteels C, De Ceuninck L, Vanbilloen B, Maes A, Mortelmans L, et al. Dual-tracer dopamine transporter and perfusion SPECT in differential diagnosis of parkinsonism using template-based discriminant analysis. J Nucl Med : Off Publ Soc Nucl Med. 2006;47(3):384–92.

    Google Scholar 

  10. Kim JS, Cho H, Choi JY, Lee SH, Ryu YH, Lyoo CH, et al. Feasibility of computed tomography-guided methods for spatial normalization of dopamine transporter positron emission tomography image. PLoS One. 2015;10(7):e0132585. doi:10.1371/journal.pone.0132585.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Imabayashi E, Matsuda H, Tabira T, Arima K, Araki N, Ishii K, et al. Comparison between brain CT and MRI for voxel-based morphometry of Alzheimer’s disease. Brain Behav. 2013;3(4):487–93. doi:10.1002/brb3.146.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Sasaki K, Maikusa N, Imabayashi E, Yuasa T, Matsuda H. The feasibility of 11C-PIB-PET/CT for amyloid plaque burden: validation of the effectiveness of CT-based partial volume correction. Brain Behav. 2016. doi:10.1002/brb3.532.

    PubMed  PubMed Central  Google Scholar 

  13. Ashburner J. A fast diffeomorphic image registration algorithm. NeuroImage. 2007;38(1):95–113. doi:10.1016/j.neuroimage.2007.07.007.

  14. Hammers A, Allom R, Koepp MJ, Free SL, Myers R, Lemieux L, et al. Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe. Hum Brain Mapp. 2003;19(4):224–47. doi:10.1002/hbm.10123.

    Article  PubMed  Google Scholar 

  15. Varrone A, Dickson JC, Tossici-Bolt L, Sera T, Asenbaum S, Booij J, et al. European multicentre database of healthy controls for [123I]FP-CIT SPECT (ENC-DAT): age-related effects, gender differences and evaluation of different methods of analysis. Eur J Nucl Med Mol Imaging. 2013;40(2):213–27. doi:10.1007/s00259-012-2276-8.

    Article  CAS  PubMed  Google Scholar 

  16. Lapa C, Spehl TS, Brumberg J, Isaias IU, Schlogl S, Lassmann M, et al. Influence of CT-based attenuation correction on dopamine transporter SPECT with [(123)I]FP-CIT. Am J Nucl Med Mol Imaging. 2015;5(3):278–86.

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hiroshi Matsuda.

Ethics declarations

Funding

This study was supported by a grant from the Japan Foundation for Neuroscience and Mental Health and intramural research grant for neurological and psychiatric disorders of National Center of Neurology and Psychiatry (27-8).

Conflicts of interest

None.

Research involving human participants and/or animals

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors.

Informed consent

This retrospective study was approved by the institutional review board at the National Center of Neurology and Psychiatry Hospital, and the need for patient informed consent was waived.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yokoyama, K., Imabayashi, E., Sumida, K. et al. Computed-tomography-guided anatomic standardization for quantitative assessment of dopamine transporter SPECT. Eur J Nucl Med Mol Imaging 44, 366–372 (2017). https://doi.org/10.1007/s00259-016-3496-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-016-3496-0

Keywords

Navigation